Table 2.
Compounds | Concentrations (µg mL−1) | ||||
---|---|---|---|---|---|
1 | 10 | 100 | 500 | 1000 | |
4a | 148.28 b * | 145.33 b | 78.78 b | 37.40 b | 18.61 b |
4b | 145.15 b | 125.40 c | 71.61 c | 37.66 b | 17.51 b |
4c | 128.30 c | 99.06 d | 45.69 f | 37.04 b | 19.83 b |
4d | 102.16 e | 85.48 e | 66.66 d | 13.79 e | 2.49 d |
4e | 114.46 d | 74.59 g | 58.13 e | 28.10 c | 19.00 b |
4f | 112.30 d | 79.54 f | 49.54 f | 19.34 d | 4.68 c |
4g | 86.72 f | 46.18 h | 30.28 h | 12.26 e | 2.99 d |
4h | 83.04 f | 74.41 i | 41.60 g | 10.20 e | 3.45 c |
Tebuconazole | 9.35 g | 3.28 m | 0.00 i | 0.00 f | 0.00 e |
Control | 206.70 a | 206.70 a | 206.70 a | 206.70 a | 206.70 a |
* Means followed by the same letter in the column do not differ at 5% probability by the Scott- Knott test.